Terfenadin, Setirizin, Loratadin ve Akrivastinin kalp üzerine olan etkilerinin değerlendirilmesi

Simple item page
dc.citation.epage140en_US
dc.citation.issueNumber3en_US
dc.citation.spage139en_US
dc.citation.volumeNumber31en_US
dc.contributor.authorErel, A.en_US
dc.contributor.authorOztas, M. O.en_US
dc.contributor.authorAlkan, M.en_US
dc.contributor.authorIlter, N.en_US
dc.contributor.authorGurer, M. A.en_US
dc.date.accessioned2016-02-08T10:46:56Z
dc.date.available2016-02-08T10:46:56Z
dc.date.issued1997en_US
dc.description.abstractDesign. - Non-sedative antihistanimic drugs, terfenadine, cetinizine, loratadine and acrivastine were given to four groups of patients each consisted of 10 patients for 10 days. Blood chemistry and daily electrocardrographic changes were followed. Conclusion. - Non-sedative antihistaminics have no cardiac side effects as they are given alone, in conventional treatment dose.en_US
dc.identifier.issn1308-6294
dc.identifier.urihttp://hdl.handle.net/11693/25568
dc.language.isoTurkishen_US
dc.publisherGalenos Yayinevien_US
dc.source.titleTurkderm : Archives of the Turkish Dermatology and Venerologyen_US
dc.subjectAcrivastineen_US
dc.subjectCetirizineen_US
dc.subjectHearten_US
dc.subjectLoratadineen_US
dc.subjectTerfenadineen_US
dc.titleTerfenadin, Setirizin, Loratadin ve Akrivastinin kalp üzerine olan etkilerinin değerlendirilmesien_US
dc.title.alternativeCardiovascular effects of terfenadine, cetirisine and laratodineen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
bilkent-research-paper.pdf
Size:
68.58 KB
Format:
Adobe Portable Document Format
Download

Collections

Scholarly Publications - Work in Progress